Lumega-Z
Commercial- Indications
- Age-related Macular Degeneration
Company intelligence / Profile preview
Guardion Health Sciences
Houston, Texas, United Statesguardionhealth.com ↗
- Ownership
- Public · GHSI
- Employees
- ~9
- Development stage
- Commercial
01
Overview
Prior to ceasing operations in October 2024, Guardion marketed clinically supported medical foods and dietary supplements focused on ocular health and general nutrition. Its main commercial products included GlaucoCetin for mitochondrial function in glaucoma patients, Lumega-Z for macular pigment restoration in AMD patients, and the Viactiv line of bone-health supplements. The company experienced declining revenues before selling its Viactiv business and entering voluntary liquidation.
- Therapeutic areas
- OphthalmologyEndocrinologyMetabolic Disorders
- Modalities
- Medical foodDietary supplementSmall moleculeOmega fatty acid supplementAntioxidant therapy
- Industry
- Food & Nutrition
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
No major pharmaceutical or biotech partnerships disclosed; distribution through major retailers such as Walmart, Target, CVS
04
Financials
- Market cap
- $4.2M
- Total revenue
- $72.9K
- Enterprise value
- $-10.6M
Beyond the preview
Go deeper on Guardion Health Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guardion Health Sciences.